About
Kenneth J. Gorelick is the Managing Director at Zymo Consulting Group. He attended the University at Buffalo. Kenneth Gorelick, M.D. has 20 years of experience in the development of drugs and biologics in the human health care sector. He is currently President and Chief Operating Officer of Enzybiotics, LLC, a privately held biotechnology company and a consultant to the pharmaceutical industry. Dr. Gorelick has expertise with numerous approvals of BLAs, NDAs and MAAs. Prior to these assignments, Dr. Gorelick held the position of Vice President of Global Clinical Research and Development at Dupont Merck Research Laboratories, Inc. a research-driven pharmaceutical company. He was also Vice President of Drug Development at Genelabs, a biotechnology company focused on infectious and autoimmune disease.
Position in the VCSift Database
- • 1,801 investors hold the Managing Director role in VCSift. Kenneth J. Gorelick is one of them.
- • 14 investors are based in Newtown Square, Pennsylvania, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Newtown Square, US
Contact Information
Find more investors like Kenneth J.
Search Investors